Who are Aesculus hippocastanum, and associations's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/aesculus-hippocastanum-and-associations.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Aesculus hippocastanum, and associations — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aesculus hippocastanum, and associations (Aesculus hippocastanum, and associations) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Phlebotonic agent. Area: Cardiovascular / Vascular disorders.

marketed Herbal extract / Phlebotonic agent Aescin (triterpene saponin); non-specific vascular and anti-inflammatory targets Cardiovascular / Vascular disorders Small molecule Live · refreshed every 30 min

Target snapshot

Aesculus hippocastanum, and associations (Aesculus hippocastanum, and associations) — Fundação Educacional Serra dos Órgãos. Aesculus hippocastanum (horse chestnut seed extract) reduces inflammation and improves venous tone through its active constituent aescin, which stabilizes capillary membranes and reduces vascular permeability.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Aesculus hippocastanum, and associations TARGET	Aesculus hippocastanum, and associations	Fundação Educacional Serra dos Órgãos	marketed	Herbal extract / Phlebotonic agent	Aescin (triterpene saponin); non-specific vascular and anti-inflammatory targets

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Phlebotonic agent class)

Fundação Educacional Serra dos Órgãos · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Aesculus hippocastanum, and associations — Competitive Intelligence Brief. https://druglandscape.com/ci/aesculus-hippocastanum-and-associations. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab